expanding the universe of cancer therapies
Targeting cancer aneuploidy
Targeting cancer aneuploidy
KaryoVerse Therapeutics is a leading biotechnology company dedicated to the discovery and development of innovative cancer therapies. By targeting cancer aneuploidy, our cutting-edge technologies aim to generate a new universe of therapeutics to fight this devastating disease.
One Broadway, 14th Floor, Cambridge, MA 02142, United States
Copyright © 2024 KaryoVerse - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.